Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 30, 2018
Kitov Announces Settlement of Shareholder Class Action Litigation
Tel Aviv, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV.TA), an innovative biopharmaceutical company, today announced that it has ...
July 30, 2018
BioDelivery Sciences Appoints Thomas Smith, MD as Chief Medical Officer Further Expanding Company’s Expertise in Field of Pain Management
RALEIGH, N.C., July 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a leading commercial based specialty pharmaceutical company focused on patients living with ...
July 30, 2018
Soleno Therapeutics Receives Fast Track Designation from FDA for DCCR for Treatment of Prader-Willi Syndrome
REDWOOD CITY, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
July 30, 2018
Pernix Therapeutics Announces Successful Closing of Transaction Regarding Worldwide Rights to Contrave® for Weight Loss
MORRISTOWN, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, today announced the closing of a transaction in ...
July 30, 2018
DURECT Announces FDA Approval of Indivior's PERSERIS™ (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
CUPERTINO, Calif., July 30, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that Indivior PLC (INDV.L) has reported that the U.S. Food and Drug Administration (FDA) has approved ...
July 30, 2018
Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer
Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that the U.S. Food and Drug Administration ...
July 30, 2018
AIT Therapeutics Announces Start of Manufacturing of Ventilator Compatible NO Generator and Delivery System
GARDEN CITY, N.Y. and REHOVOT, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
July 27, 2018
Achaogen Announces Strategic Update to Align Operations with Commercial and Clinical Development Priorities
SOUTH SAN FRANCISCO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug ...
July 27, 2018
MannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018
WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) will host a conference call to discuss the 2018 second quarter and year-to-date ...
July 26, 2018
MedDay Appoints Industry Leader Christian Chavy as Chief Executive Officer
PARIS, July 26, 2018 (GLOBE NEWSWIRE) -- MedDay, a pioneering pharmaceutical company focused on the treatment of nervous system disorders, today announces the appointment of ...
July 26, 2018
CytoSorbents to Report Q2 2018 Operating and Financial Results
MONMOUTH JUNCTION, N.J., July 26, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and ...
July 26, 2018
Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints
BUFFALO, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
July 26, 2018
ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission
RAMSEY, N.J. and BOCA RATON, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
July 26, 2018
Genocea to Host Second Quarter 2018 Financial Results Conference Call & Webcast on August 2, 2018 at 9:00 a.m. ET
CAMBRIDGE, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc.(GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a ...
July 26, 2018
Galmed Pharmaceuticals to Report Second Quarter 2018 Financial Results and Provide Business Update on Thursday, August 2
TEL AVIV, Israel, July 26, 2018 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmedˮ or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
July 25, 2018
BrainStorm Announces Grant of a New European Patent for NurOwn®
NEW YORK and PETACH TIKVAH, Israel, July  25, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today ...
July 25, 2018
PureTech Health Collaborator Publishes in Journal Nature Regarding New Insights into Key Role of Brain Lymphatics in Alzheimer’s and Other Neurodegenerative Diseases
PureTech Health plc (PRTC.L) ("PureTech Health"), a clinical-stage biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG), today notes the publication of foundational ...
July 25, 2018
Pfenex to Host Conference Call and Webcast Reporting Second Quarter Financial Results on Wednesday, August 8
SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE AMERICAN:PFNX) a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression ...
July 25, 2018
Conatus Pharmaceuticals to Report Second Quarter 2018 Financial Results
SAN DIEGO , July 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced that it will report financial results for the second quarter ...
July 25, 2018
miRagen Therapeutics to Report Second Quarter 2018 Financial Results and Host Conference Call on August 7, 2018
BOULDER, Colo., July 25, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, ...
Page 46 of 138